# Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

> **NCT07207291** · PHASE1 · RECRUITING · sponsor: **Joincare Pharmaceutical Group Industry Co., Ltd** · enrollment: 66 (estimated)

## Conditions studied

- Bacterial Infections
- Urinary Tract Infections
- Intra-Abdominal Infections
- Respiratory Tract Infections

## Interventions

- **DRUG:** JKN2501
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07207291
- **Lead sponsor:** Joincare Pharmaceutical Group Industry Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-22
- **Primary completion:** 2026-03-19
- **Final completion:** 2026-03-19
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07207291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07207291, "Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07207291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*